The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database
- PMID: 15246183
- DOI: 10.1016/j.lungcan.2004.01.019
The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database
Abstract
Bronchioloalveolar carcinoma of the lung (BAC) is a subtype of adenocarcinoma of the lung. Although traditionally grouped with other non-small cell lung carcinomas (NSCLC), BAC has unique morphological features and clinical behavior such as bilateral lung involvement, indolent course and lack of association with smoking. Some epidemiologic studies report a significant increase in the incidence of BAC. We used the SEER database to compare the incidence, demographics, and overall survival of BAC patients as compared to other NSCLC types over the past two decades (1979-1998). Although the incidence of BAC has increased over the past two decades, BAC represents less than 4% of all NSCLC in every time period evaluated. The 1 year survival rate is significantly better for BAC patients relative to other histological subtypes of NSCLC. There has not been a marked increase in the incidence of BAC reported to SEER over the past 20 years.
Similar articles
-
[The occurrence of bronchioloalveolar lung cancer among our patients].Magy Onkol. 2003;47(4):349-53. Epub 2004 Jan 11. Magy Onkol. 2003. PMID: 14716429 Hungarian.
-
Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.Ann Thorac Surg. 2004 Nov;78(5):1728-33. doi: 10.1016/j.athoracsur.2004.05.017. Ann Thorac Surg. 2004. PMID: 15511463 Review.
-
A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy.Cancer. 2008 Apr 1;112(7):1547-54. doi: 10.1002/cncr.23289. Cancer. 2008. PMID: 18260087
-
Clinical investigation of bronchioloalveolar carcinoma: a retrospective analysis of 53 patients in a single institution.Anticancer Res. 1999 Mar-Apr;19(2B):1369-73. Anticancer Res. 1999. PMID: 10365108
-
Bronchioloalveolar carcinoma: a review of the epidemiology, pathology, and treatment.Semin Respir Crit Care Med. 2005 Jun;26(3):342-52. doi: 10.1055/s-2005-871993. Semin Respir Crit Care Med. 2005. PMID: 16052436 Review.
Cited by
-
Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer.J Hematol Oncol. 2015 Jun 11;8:67. doi: 10.1186/s13045-015-0164-y. J Hematol Oncol. 2015. PMID: 26063074 Free PMC article.
-
Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT.Biomed Res Int. 2015;2015:243681. doi: 10.1155/2015/243681. Epub 2015 Mar 24. Biomed Res Int. 2015. PMID: 25879020 Free PMC article.
-
Antiangiogenic therapy in lung cancer: focus on vascular endothelial growth factor pathway.Exp Biol Med (Maywood). 2010 Jan;235(1):3-9. doi: 10.1258/ebm.2009.009191. Exp Biol Med (Maywood). 2010. PMID: 20404013 Free PMC article. Review.
-
The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.J Thorac Oncol. 2017 Apr;12(4):689-696. doi: 10.1016/j.jtho.2017.01.003. Epub 2017 Jan 8. J Thorac Oncol. 2017. PMID: 28082103 Free PMC article.
-
Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.BMC Med. 2017 Aug 25;15(1):162. doi: 10.1186/s12916-017-0924-3. BMC Med. 2017. PMID: 28838313 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous